(Q43405959)

23 November 2017

title

Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice (English)

1 reference

23 November 2017

main subject

complement 3 deficiency

1 reference

Anne M Connolly

1

1 reference

23 November 2017

Richard M Keeling

2

1 reference

23 November 2017

Elizabeth M Streif

3

1 reference

23 November 2017

Alan Pestronk

4

1 reference

23 November 2017

Shobhna Mehta

5

1 reference

23 November 2017

publication date

1 June 2002

1 reference

Journal of Neuroimmunology

23 November 2017

published in

1 reference

23 November 2017

volume

127

1 reference

23 November 2017

issue

1-2

1 reference

23 November 2017

page(s)

80-87

1 reference

Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Activation of the alternative complement pathway and production of factor H by skeletal myotubes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Abrogation of the alternative complement pathway by targeted deletion of murine factor B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Inflammatory myopathy with facioscapulohumeral distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Serum activity of C1 inactivator in Duchenne-type progressive muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Cyclosporine increases muscular force generation in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Complement C3 deficiency: human, animal, and experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Quantitative measurement of muscle strength in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

Corticosteroid therapy does not alter the threshold for contraction-induced injury in dystrophic (mdx) mouse diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900104-2

7 January 2021

10.1016/S0165-5728(02)00104-2

Identifiers

DOI

1 reference

23 November 2017

1 reference